News Breaks |
|
|
| October 4, 2012 |
| 07:53 EDT |  | ONCS, DNDN, IMUC, PBMD, VICL, PVCT, NWBO, IDRA, AGEN, BPAX, GALE, NLNK | BD Becker Partners to host a conference
3rd Annual Cancer Immunotherapy: A Long-Awaited Reality Conference is being held in New York on October 4. |
|
|
News For ONCS;GALE;BPAX;AGEN;IDRA;NWBO;PVCT;VICL;PBMD;IMUC;DNDN;NLNK From The Last 14 Days Check below for free stories on ONCS;GALE;BPAX;AGEN;IDRA;NWBO;PVCT;VICL;PBMD;IMUC;DNDN;NLNK the last two weeks. |
|
|
| May 21, 2013 |
| 07:44 EDT | | ONCS | Sachs Associates to host a forum
 Subscribe for More Information |
|
| May 16, 2013 |
| 08:18 EDT |  | NWBO | Northwest Biotherapeutics initiates Phase III DCVax-L brain cancer trial
Subscribe for More Information |
|
| 06:02 EDT | | IMUC | ImmunoCellular announces issuance of key patent covering cancer vaccine target
Subscribe for More Information |
|
| May 15, 2013 |
| 08:20 EDT |  | IDRA | Idera Pharmaceuticals reports Q1 EPS (15c), one estimate (19c)
Subscribe for More Information |
|
| May 10, 2013 |
| 10:00 EDT |  | DNDN | On The Fly: Analyst Downgrade Summary
Subscribe for More Information |
|
| 09:38 EDT |  | DNDN | Active equity option families trading
Subscribe for More Information |
|
| 09:21 EDT | | DNDN | On The Fly: Pre-market Movers
Subscribe for More Information |
|
| 07:55 EDT |  | DNDN | Dendreon may generate near-term trading opportunity, says RW Baird
Subscribe for More Information |
|
| 07:44 EDT | | DNDN | Dendreon price target lowered to $1 from $5 at BofA/Merrill
Subscribe for More Information |
|
| 07:40 EDT | | DNDN | Dendreon price target lowered to $6.50 from $9 at Bernstein
Subscribe for More Information |
| |
| 05:51 EDT | | DNDN | Dendreon downgraded to Sell from Neutral at Citigroup
Subscribe for More Information |
|
| May 9, 2013 |
| 16:23 EDT | | GALE | Galena Biopharma reports Q1 EPS (11c), consensus (7c)
Subscribe for More Information |
|
| 16:02 EDT | | IMUC | ImmunoCellular reports Q1 EPS (10c), consensus (8c)
Subscribe for More Information |
|
| 14:15 EDT | | DNDN | Dendreon downgraded to Sell from Neutral at Roth Capital
Subscribe for More Information |
|
| 13:32 EDT | | DNDN | Dendreon downgraded to Sell from Hold at Stifel
Subscribe for More Information |
|
| 12:35 EDT |  | DNDN | On The Fly: Midday Wrap
Subscribe for More Information |
|
| 10:56 EDT | | DNDN | Dendreon price target lowered to $3 from $4 at Maxim
Subscribe for More Information |
|
| 08:42 EDT | | DNDN | Dendreon reports Q1 EPS (48c), consensus (48c)
Subscribe for More Information |
|
| 07:33 EDT | | GALE | Galena Biopharma's Abstral serves as model for TIRF REMS program
Subscribe for More Information |
|
| 06:38 EDT | | VICL | Vical reports Q1 EPS (11c), consensus (11c)
Reports Q1 revenue $1.6M, consensus $2.02M. |
| |
|
|
|
|
